✦ LIBER ✦

A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A gynecologic oncology group study

✍ Scribed by George Omura; John A. Blessing; Clarence E. Ehrlich; Alexander Miller; Edgardo Yordan; William T. Creasman; Howard D. Homesley

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 593 KB
Volume: 57
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19860501)57:9<1725::aid-cncr2820570903>3.0.co;2-j

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of recurrent or advanced uteri

Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicin Versus doxorubicin and cyclophosphamide (a phase III trial of the gynecologic oncology group)

✍ Hyman B. Muss; Brian Bundy; Philip J. Disaia; Howard D. Homesley; Wesley C. Fowl 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 524 KB

A randomized trial of doxorubicin versus

A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma

✍ Katsutaro Shimaoka; David A. Schoenfeld; William D. Dewys; Richard H. Creech; Ro 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB 👁 2 views

The prognostic value of pretreatment CA

The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma : A Gynecologic Oncology Group study

✍ Kristin K. Zorn; Chunqiao Tian; William P. McGuire; William J. Hoskins; Maurie M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB 👁 2 views

Randomized trial of 5-fluorouracil and m

Randomized trial of 5-fluorouracil and mitomycin C with or without streptozotocin for advanced pancreatic cancer. A Southwest oncology group study

✍ Ronald M. Bukowski; Stanley P. Balcerzak; Robert M. O'Bryan; John D. Bonnet; T. 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB 👁 2 views

Responsiveness of patients with advanced

Responsiveness of patients with advanced ovarian carcinoma to tamoxifen. A gynecologic oncology group study of second-line therapy in 105 patients

✍ Kenneth D. Hatch; Jackson B. Beecham; John A. Blessing; William T. Creasman 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB 👁 2 views

Phase II trial of carboplatin and paclit

Phase II trial of carboplatin and paclitaxel in cisplatin-pretreated advanced transitional cell carcinoma : A Southwest Oncology Group study

✍ Ulka N. Vaishampayan; James R. Faulkner; Eric J. Small; Bruce G. Redman; Wayne L 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

## Abstract ## BACKGROUND The purpose of the study was to assess the efficacy and toxicity of carboplatin and paclitaxel administered every 3 weeks in patients with advanced urothelial carcinoma, previously treated with cisplatin‐based therapy. ## METHODS Eligibility included metastatic or local